AstraZeneca enters late-stage COVID-19 vaccine trial
 Multinational pharmaceutical company AstraZeneca announced it has started Phase III clinical trials in the United States of its COVID-19 candidate vaccine.   from Latest News - UPI.com https://ift.tt/3hKLB7G  via IFTTT